Looking for a Biotech Stock That's an Ideal Buyout Candidate? This Is It.
It's a familiar story. A small biotech gets really good news about a promising drug. A big drugmaker with deep pockets is looking for a way to fuel growth. The big drugmaker thinks the small biotech's drug is a good fit with its own lineup and acquires the small biotech. And investors who owned shares of said small biotech make a boatload of money.
If you're the kind of investor who looks for biotech stocks that are likely to have this story play out, there's one stock that I think ranks at the top of the list. In my view, there's no more ideal buyout candidate right now than Amarin (NASDAQ: AMRN).
Image source: Getty Images.
Source Fool.com
